NCT04755764Recruiting
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
The Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by Impedance Cardiography in Early Pregnancy
Source: ClinicalTrials.gov · Last updated 13 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 27 Jan 2021
- Start date
- 3 Mar 2021
- Primary completion date
- Dec 2025
- Lead sponsor
- Marshall University
- Diseases
- High blood pressure
- NCT number
- NCT04755764
What you commit to
- Study type: Observational
- Planned participants: 60
- From 3 Mar 2021 to the primary completion date, Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- \<18 years old or \>45 years old
- Gestational age \>15 weeks
Other
- Non-English speaking patients, patients
- Not willing or able to provide consent
Who the study is looking for
- Patients presenting to Maternal Hypertension Center at Cabell Huntington Hospital
- English speaking
- 18-45 years old.
- Willing to provide informed consent
- Gestational age prior to 15 weeks gestation
Age in the registry: 18 years to 45 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Maternal Hypertension Center at Cabell Huntington Hospital Coordinator of this site? Confirm its status | Huntington | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.